Search
for
Sort by
Research 421–450 of 1000+
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Alterations in nasal mucociliary activity in polycystic ovary syndrome
- Management of Hirsutism Associated With Obese PCOD - A Case Report
- MON-323 Metastatic Adrenocortical Carcinoma Presenting with Mixed Cushing's and Virilization Syndrome along with Bilateral Pulmonary Emboli
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Emerging medication for the treatment of male hypogonadism
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Side gland of Suncus murinus as a new model of sebaceous gland: 5?-reductase, androgen receptor, and nuclear androgen content in male and female animals
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- ラット精巣におけるビタミンD 代謝関連遺伝子の発現解析
- Frequency of polycystic ovarian syndrome in women with postadolescent acne
- Parenteral and Oral Cyproterone Acetate Treatment in Severe Hirsutism
- Clinicopathological, trichoscopic and biochemical parameters in females with patterned hair loss
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain
- Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Dutasteride‐mediated morphological changes in the genitourinary tract associated with altered expression patterns of the androgen and estrogen receptors in male rats
- Low-dose spironolactone in the treatment of female hirsutism.
- Hyperandrogenism in PCOS
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of
- Ginsenoside CK inhibits androgenetic alopecia by regulating Wnt/β‐catenin and p53 signaling pathways in AGA mice
- Telogen effluvium on the unilateral flank with testicular tumor in a dog
- Therapeutic Potentiality of Celtis choseniana Nakai on Androgenic Alopecia through Repression of Androgen Action and Modulation of Wnt/β-catenin Signaling
- Low Anabolic Profile in Assessing a Patients Overall Hair Loss
- Finasteride and male fertility
- Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry